SPPI News and Press, Spectrum Pharmaceuticals Inc. From 07/29/20

Spectrum Pharmaceuticals, Inc. (Nasdaq-GS: SPPI) (“Spectrum”), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. All of the sha...

Spectrum Pharmaceuticals (NASDAQ: SPPI) , a small-cap biotech, is up big today following a positive midstage readout for its non-small cell lung cancer (NSCLC) drug poziotinib. Specifically, the drugmaker's shares are up by 23% on heavy volume as of 11:11 a.m. EDT Tuesday morning.   Poz...

Eastman Kodak (NYSE: KODK ) +190% . More news on: Eastman Kodak Company, Spectrum Pharmaceuticals, Inc., Soligenix, Inc., Stocks on the move, , Read more ...

These Robinhood Penny Stocks Are Catching A Lot More Attention This Week Why buy penny stocks on Robinhood ? You’ve obviously got your pick of any broker out there offering access to stocks under $5 , right? So what makes Robinhood so popular for trading them? Despite all of the short...

Spectrum Pharmaceuticals (NASDAQ: SPPI ) announces positive results from cohort 2 in a Phase 2 clinical trial, ZENITH20 , evaluating poziotinib in previously treated non-small cell lung cancer (NSCLC) patients with HER2 exon 20 insertion mutations. More news on: Spectrum Pharmaceutica...

Management to host webcast and conference call today at 4:30 p.m. ET / 1:30 p.m. PT Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that it met the pre-specified primary endpoint in the ZENI...

IRVINE, Calif. , July 16, 2020 /PRNewswire/ -- Tarsus Pharmaceuticals, a clinical-stage biopharmaceutical company, today announced the appointment of two pharmaceutical veterans to its executive leadership team: Sesha Neervannan to the position of Chief Operating Officer (COO), and Leo G...

The second half of the year could provide some solid wins for investors in the cancer therapeutics market. In recent years, Wall Street has flocked to many of these biotechnology companies because of their potential to deliver cutting-edge treatments and generate long-term returns. As cancer ...

Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced preclinical data evaluating the administration of ROLONTIS ® (eflapegrastim) on the same day as chemotherapy. The duration of neutropenia in a ...

Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a poster presentation of the results for preclinical studies evaluating the administration of ROLONTIS on the same day as chemotherapy in a rodent mo...